Mount Yale Investment Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Mount Yale Investment Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$300K	Buy	3,619 +63	+2%	+$5.05K	0.01%	977
2026 Q1	$273K	Buy	+3,556	New	+$278K	0.01%	936
2025 Q3	–	Sell	-3,760	Closed	-$245K	–	718
2025 Q2	$245K	Buy	+3,760	New	+$245K	0.02%	511
2018 Q4	–	Sell	-1,879	Closed	-$104K	–	339
2018 Q3	$104K	Buy	1,879 +129	+7%	+$7.89K	0.02%	427
2018 Q2	$117K	Hold	1,750	–	–	0.02%	411
2018 Q1	$102K	Buy	+1,750	New	+$111K	0.02%	444

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mount Yale Investment Advisors's ANIP Position: Q2 2026 in Review

Mount Yale Investment Advisors increased its ANI Pharmaceuticals (ANIP) stake by 1.8% in Q2 2026, buying an estimated $5.05K and bringing the position to 3,619 shares worth $300K. The position accounts for 0.01% of the portfolio, ranked #977.

Mount Yale Investment Advisors first reported a position in ANIP in Q1 2018 and has held it in 6 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Mount Yale Investment Advisors held 3,619 shares of ANI Pharmaceuticals worth $300K as of Q2 2026.
Mount Yale Investment Advisors bought 63 ANI Pharmaceuticals shares in Q2 2026, an estimated $5.05K.
ANI Pharmaceuticals made up 0.01% of Mount Yale Investment Advisors's portfolio in Q2 2026, its #977 holding.
Mount Yale Investment Advisors first reported a position in ANI Pharmaceuticals in Q1 2018 and has held it in 6 quarters since.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.